Silver Arch Bio

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Apr 1, 2024	Endeavor BioMedicines	$130.0M Series C	AyurMaya, Karan Takhar	Atlas Venture, Hatteras Venture Partners, Omega Funds, RA Capital, Roche Venture Fund, abrdn, Ally Bridge Group, Avidity Partners, Eckuity Capital, Fidelity Management & Research Company, Invus, Longitude Capital, Perceptive Advisors, Piper Heartland Healthcare Capital, SymBiosis, T. Rowe Price Associates, Velosity Capital, Woodline Partners

Total Raised

N/A

Valuation

N/A